Buy & Sell IDEXX Laboratories, Inc. (IDXX) – IDEXX Laboratories, Inc. Price Today
Aura AI Summary
Key Stats
- $44.18BMarket Cap
- HealthSector
- -16.2%3M Drawdown
- $45.09BEnterprise Value
- -Dividend Yield
- 43 daysTypical Hold Time
IDEXX Laboratories, Inc. (IDXX) is currently valued at a market capitalization of $44.18B, with an enterprise value of $45.09B. Over the past 52 weeks, IDEXX Laboratories, Inc. has traded between a low of $491.7 and a high of $766.68, highlighting its annual price range. Over the past three months, IDEXX Laboratories, Inc. has recorded a drawdown of -16.2%, reflecting recent price volatility. On average, investors hold IDEXX Laboratories, Inc. for approximately 43 days, indicating typical investor behavior on the platform.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Most Recent News
ABB invests $200M in Europe to boost medium-voltage tech for power grid modernization.
ABB is investing $200 million over three years to expand its medium-voltage manufacturing capacity across Europe, including a $100 million facility in Italy and projects in Bulgaria, Finland, Germany, Norway, and Poland. This investment aims to suppo...
Poolbeg Pharma wins Canadian patent for cancer drug POLB 001 to prevent dangerous immune reactions
Poolbeg Pharma has secured a Canadian patent for its drug candidate POLB 001, which aims to prevent cytokine release syndrome (CRS), a severe immune reaction caused by some cancer immunotherapies. This patent follows a similar approval in Australia a...
VCI Global signs binding term sheet to invest in Brazilian gold mining asset with 59.9 tons estimated gold resource.
VCI Global Limited has signed a binding term sheet to strategically invest in a mature gold mining asset in Brazil, estimated to contain about 59.9 tons of gold. The investment aligns with the company's strategy to integrate physical gold into its re...